differencesbetweenthe premorbid groups on change onthe Positive and Negative Syndrome Scale,Clinical Global Impression severity and cognitive functioningand Extrapyramidal Symptoms Rating Scale.Patients inthe ‘stable^good’premorbid group (n1⁄4251) improvedmore thanthose in the‘stable^ poor’ (n1⁄4198) and‘declining’ (n1⁄481) groups.The‘stable^good’group received the lowestdoses of antipsychotic andhad
نویسندگان
چکیده
Results Therewere significant differencesbetweenthe premorbid groups on change onthe Positive and Negative Syndrome Scale,Clinical Global Impression severity and cognitive functioningand Extrapyramidal Symptoms Rating Scale.Patients inthe ‘stable^good’premorbid group (n1⁄4251) improvedmore thanthose in the‘stable^ poor’ (n1⁄4198) and‘declining’ (n1⁄481) groups.The‘stable^good’group received the lowestdoses of antipsychotic andhad the leastextrapyramidal symptoms. Patients inthe‘declining’group had the highestdosages and themost extrapyramidal symptoms.
منابع مشابه
Relationship between premorbid functioning and symptom severity as assessed at first episode of psychosis.
OBJECTIVE Investigating the relationship between premorbid and prodromal status and the clinical manifestations of the first psychotic episode is relevant for understanding the pathophysiology of psychosis and for improving management of the disease. This study examined patterns of premorbid functioning of persons interviewed during their first episode of psychotic illness and examined the rela...
متن کاملEvaluation of the efficacy and safety of pregabalin as an adjuvant to antipsychotics in patients with chronic schizophrenia: a six-week pilot double-blind placebo-controlled trial
Introduction and objectives: Antipsychotics or dopamine receptor antagonists are the major components of treatment but about 10-20% of patients with schizophrenia do not benefit from treatment with antidopaminergic agents, indicating other neuronal systems may be involved in this disorder (2). Dysregulation of both excitatory and inhibitory mechanisms N-Methyl-D-aspartic acid (NMDA) and γ-Amino...
متن کامل[Augmentation of antipsychotics with glycine may ameliorate depressive and extrapyramidal symptoms in schizophrenic patients--a preliminary 10-week open-label study].
AIM The objective of this study was to analyze the changes in depressive and extrapyramidal symptomatology during glycine augmentation of antipsychotic treatment in patients with schizophrenia. MATERIALS AND METHODS Twenty-nine schizophrenic patients (ICD-10) with predominant negative symptoms in stable mental state participated in a 10-week open-label prospective study. Patients received sta...
متن کاملEfficacy and tolerability of switching to ziprasidone from olanzapine, risperidone or haloperidol: an international, multicenter study.
To compare the effectiveness of a switch from haloperidol (N=99), olanzapine (N=82), or risperidone (N=104) to 12 weeks of treatment with 80-160 mg/day ziprasidone in patients with stable schizophrenia or schizoaffective disorder. Stable outpatients with persistent symptoms or troublesome side effects were switched using one of three 1-week taper/switch strategies as determined by the investiga...
متن کاملLong-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
BACKGROUND Long-acting injectable antipsychotics may improve medication adherence, thereby improving overall treatment effectiveness. This study aimed to evaluate the effectiveness, safety, and tolerability of risperidone long-acting injection in schizophrenic patients switched from oral antipsychotic medication. METHODS In a 12-month, multicenter, open-label, noncomparative study, symptomati...
متن کامل